BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//LifeSci Events - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:LifeSci Events
X-ORIGINAL-URL:https://lifescievents.com
X-WR-CALDESC:Events for LifeSci Events
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261112T100000
DTEND;TZID=America/New_York:20261112T120000
DTSTAMP:20261014T140702Z
CREATED:20261007T165903Z
LAST-MODIFIED:20261014T140702Z
UID:3660-1794477600-1794484800@lifescievents.com
SUMMARY:Minerva Neurosciences In-Person & Virtual Event: Roluperidone for Negative Symptoms of Schizophrenia
DESCRIPTION:Join Minerva Neurosciences for an in-person and virtual event featuring several key opinion leaders and company management to discuss the unmet need and current landscape related to the treatment of negative symptoms of schizophrenia. Management will also discuss new analytical evidence supporting roluperidone’s efficacy as well as other important company updates. \nRoluperidone\, an investigational therapy for negative symptoms of schizophrenia\, is the only monotherapy treatment to date\, to demonstrate significant meaningful improvements on primary negative symptoms of schizophrenia. Currently\, no FDA-approved therapies exist for negative symptoms\, and roluperidone remains the only late-stage drug in development targeting primary negative symptoms. \nDuring the event\, company management will also review the market opportunity for roluperidone. A live question and answer session will follow the formal presentations. Watch the webcast by clicking this link and logging in with the email address you used to register: https://lifescievents.com/event/mvt75p9/.
URL:https://lifescievents.com/event/mvt75p9/
LOCATION:New York\, NY and Live Webcast\, New York\, NY and Live Webcast
ATTACH;FMTTYPE=image/png:https://lifescievents.com/wp-content/uploads/2026/10/Events-Banners_2-35-1.png
END:VEVENT
END:VCALENDAR